Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital, End-point), By Product, By Application- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global real-time PCR, digital PCR, and end-point PCR market size was exhibited at USD 34.32 billion in 2022 and is projected to hit around USD 76.18 billion by 2032, growing at a CAGR of 8.3% during the forecast period 2023 to 2032.

Real-time PCR, Digital PCR, And End-point PCR Market Size

Key Pointers:

  • The clinical segment held the largest revenue share of over 86.7% in 2022.
  • The consumables and reagents segment held the largest revenue share of over 61.17% in 2022.
  • The quantitative PCR segment held the largest revenue share of over 86.7% in 2022. 
  • North America dominated the global market with a revenue share of over 36.9% in 2022

 Real-time PCR, Digital PCR, And End-point PCR Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 37.17 Billion

Market Size by 2032

USD 76.18 Billion

Growth Rate from 2023 to 2032

CAGR of 8.3%

Base year

2022

Forecast period

2023 to 2032

Segments covered

Technology, Application, Product

Regional scope

North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa

Key companies profiled

Bio-Rad Laboratories; Thermo Fisher Scientific Inc.; Qiagen; Abbott; Agilent Technologies, Inc.; bioMerieux; Fluidigm Corporation; F. Hoffmann-La Roche Ltd.

 

The real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2032. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years.

The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.

Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.

Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.

Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period. 

Some of the prominent players in the Real-time PCR, digital PCR, and end-point PCR Market include:

  • Abbott
  • Qiagen
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • BIOMÉRIEUX
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Real-time PCR, digital PCR, and end-point PCR market.

By Technology 

  • Quantitative
    • Consumables & Reagents
    • Instruments
    • Software & Services
  • Digital
    • Consumables & Reagents
    • Instruments
    • Software & Services
  • End-point
    • Consumables & Reagents
    • Instruments
    • Software & Services

By Product 

  • Consumables & Reagents
  • Instruments
  • Software & Services

By Application 

  • Clinical
    • Pathogen Testing
    • Oncology testing
    • Blood Screening
    • Liquid Biopsy
    • dPCR-based Non-invasive Prenatal Testing (NIPT)
    • Others
  • Research
  • Stem Cell Research
    • DNA Cloning & Sequencing
    • Recombinant DNA Technology
    • Rare Mutation Detection
    • Gene Expression
    • Single Cell Analysis
    • Microbiome Analysis
    • Copy Number Variation Analysis
    • Library Quantification (NGS)
    • Characterization of Low-fold Changes in mRNA and miRNA
    • Expression"
    • Species Identification
    • GMO Detection
    • Others
  • Forensic

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global real-time PCR, digital PCR, and end-point PCR market size was exhibited at USD 34.32 billion in 2022 and is projected to hit around USD 76.18 billion by 2032

The global real-time PCR, endpoint PCR, and digital PCR market is anticipated to decline at a compound annual growth rate of 8.3% from 2023 to 2032

Some key players operating in the real-time PCR, endpoint PCR, and digital PCR market include Bio-Rad Laboratories Inc.; Thermo Fisher Scientific, Inc.; Qiagen; Abbott; Agilent Technologies, Inc.; BIOMÉRIEUX; Fluidigm Corporation.; and F. Hoffmann-La Roche Ltd.

Key factors that are driving the real-time PCR, endpoint PCR, and digital PCR market growth include the high prevalence of target diseases and rapid technological advancements such as the development of high-performance and superior qPCR and dPCR systems.

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation
                       1.1.1 Segment Scope
                       1.1.2 Regional Scope
                       1.1.3 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Nova one advisor’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                           1.6.1.1 Approach 1: Commodity Flow Approach
                           1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
                   1.7 Global Market: Cagr Calculation
                   1.8 List Of Secondary Sources
                   1.9 Objectives
                       1.9.1 Objective 1:
                       1.9.2 Objective 2:
                   1.10 List of Abbreviations
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 Real-time PCR (qPCR) Market - Industry Outlook
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market Lineage Outlook
                       3.1.2 Related/Ancillary Market Outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 Market Dynamics
                       3.3.1 Market Drivers
                           3.3.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
                           3.3.1.2 Technological advancements in PCR
                           3.3.1.3 Implementation of MIQE guidelines
                           3.3.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies
                           3.3.1.5 Increasing number of CROs and forensic & research laboratories
                           3.3.1.6 Increasing demand for prenatal genetic testing procedures
                       3.3.2 Market Restraint Analysis
                           3.3.2.1 High device costs associated with Real-time PCR (qPCR)
                           3.3.2.2 Stringent regulatory policies
                   3.4 Comparative Analysis
                   3.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
                   3.6 Industry Analysis - Porter’s
                   3.7 Reimbursement & Regulatory Scenario
                   3.8 Major Deals & Strategic Alliances
                       3.8.1 New Product Launch
                       3.8.2 Acquisition
                       3.8.3 Expansion
                       3.8.4 Partnerships
                       3.8.5 Marketing & Promotions
Chapter 4 Real-time PCR (qPCR), end-point PCR, and dPCR Market: Competitive Analysis
                   4.1 Recent developments & impact analysis, by key market participants
                       4.1.1 Ansoff Matrix
                   4.2 Company Categorization
                       4.2.1 Innovators
                       4.2.2 Market Leaders
                   4.3 Vendor Landscape
                       4.3.1 List Of Key Distributors And Channel Partners
                       4.3.2 Key Customers
                   4.4 Public Companies
                       4.4.1 Company Market Position Analysis
                       4.4.2 Competitive Dashboard Analysis
                   4.5 Private Companies
                       4.5.1 List Of Key Emerging Companies
                   4.6 Regional Network Map
                   4.7 Key Regional/Local Competitors for PCR Consumables/Enzymes in Japan, Australia, Korea, India, Singapore, and Europe
Chapter 5 Real-time PCR (qPCR), end-point PCR, and dPCR Market Analysis, Technology Scope, 2020 - 2032 (Revenue, USD Million)
                   5.1 Real-time PCR (qPCR), end-point PCR, and dPCR Market: Technology Movement Analysis
                   5.2 Quantitative
                       5.2.1 Quantitative Market Estimates And Forecast, 2020 - 2032
                   5.3 Digital
                       5.3.1 Digital Market Estimates And Forecast, 2020 - 2032
                   5.4 End-Point PCR
                       5.4.1 End-Point PCR Market Estimates And Forecast, 2020 - 2032
Chapter 6 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2020 - 2032 (Revenue, USD Million)
                   6.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis
                   6.2 Consumables & Reagents
                       6.2.1 Consumables & Reagents Market Estimates And Forecast, 2020 - 2032
                   6.3 Instruments
                       6.3.1 Instruments Market Estimates And Forecast, 2020 - 2032
                   6.4 Software & Services
                       6.4.1 Software & Services Market Estimates And Forecast, 2020 - 2032
Chapter 7 Real-Time PCR (QPCR), End Point PCR, And DPCR Market Analysis, Application Scope, 2020 - 2032 (Revenue, USD Million)
                   7.1 Real-Time PCR (QPCR), End Point PCR, And DPCR Market: Application Movement Analysis
                   7.2 Clinical
                       7.2.1 Clinical Market Estimates And Forecast, 2020 - 2032
                       7.2.2 Pathogen Testing
                           7.2.2.1 Pathogen Testing Market Estimates And Forecast, 2020 - 2032
                       7.2.3 Oncology Testing
                           7.2.3.1 Oncology Testing Market Estimates And Forecast, 2020 - 2032
                       7.2.4 Blood Screening
                           7.2.4.1 Blood Screening Market Estimates And Forecast, 2020 - 2032
                       7.2.5 Liquid Biopsy Testing
                           7.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2020 - 2032
                       7.2.6 DPCR-Based Non-Invasive Prenatal Testing (NIPT)
                           7.2.6.1 DPCR-Based Non-Invasive Prenatal Testing (NIPT) Market Estimates And Forecast, 2020 - 2032
                       7.2.7 Others
                           7.2.7.1 Others Market Estimates And Forecast, 2020 - 2032
                   7.3 Research
                       7.3.1 Research Market Estimates And Forecast, 2020 - 2032
                       7.3.2 Stem Cell Research
                           7.3.2.1 Stem Cell Research Market Estimates And Forecast, 2020 - 2032
                       7.3.3 DNA Cloning & Sequencing
                           7.3.3.1 DNA Cloning & Sequencing Market Estimates And Forecast, 2020 - 2032
                       7.3.4 Recombinant DNA Technology
                           7.3.4.1 Recombinant DNA Technology Market Estimates And Forecast, 2020 - 2032
                       7.3.5 Rare Mutation Detection
                           7.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2020 - 2032
                       7.3.6 Gene Expression
                           7.3.6.1 Gene Expression Market Estimates And Forecast, 2020 - 2032
                       7.3.7 Single-Cell Analysis
                           7.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2020 - 2032
                       7.3.8 Microbiome Analysis
                           7.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2020 - 2032
                       7.3.9 Copy Number Variation Analysis
                           7.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2020 - 2032
                       7.3.10 Library Quantification (Ngs)
                           7.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2020 - 2032
                       7.3.11 Characterization Of Low-Fold Changes In mRNA And Mirna Expression
                           7.3.11.1 Characterization Of Low-Fold Changes In mRNA And Mirna Expression Market Estimates And Forecast, 2020 - 2032
                       7.3.12 Species Identification
                           7.3.12.1 Species Identification Market Estimates And Forecast, 2020 - 2032
                       7.3.13 Gmo Detection
                           7.3.13.1 Gmo Detection Market Estimates And Forecast, 2020 - 2032
                   7.4 Forensics And Others
                           7.4.1.1 Forensics And Others Market Estimates And Forecast, 2020 - 2032
Chapter 8 Real-time PCR (qPCR), end-point PCR, and dPCR Market Analysis, Regional Scope, 2020 - 2032 (Revenue, USD Million)
                   8.1 Market Share Analysis by Country, 2021 & 2032
                       8.1.1 North America
                           8.1.1.1 North America market estimates and forecast, 2020 - 2032
                           8.1.1.2 U.S.
                               8.1.1.2.1 U.S. market estimates and forecast, 2020 - 2032
                           8.1.1.3 Canada
                               8.1.1.3.1 Canada market estimates and forecast, 2020 - 2032
                       8.1.2 Europe
                           8.1.2.1 Europe market estimates and forecast, 2020 - 2032
                           8.1.2.2 U.K.
                               8.1.2.2.1 U.K. market estimates and forecast, 2020 - 2032
                           8.1.2.3 Germany
                               8.1.2.3.1 Germany market estimates and forecast, 2020 - 2032
                           8.1.2.4 France
                               8.1.2.4.1 France market estimates and forecast, 2020 - 2032
                           8.1.2.5 Italy
                               8.1.2.5.1 Italy market estimates and forecast, 2020 - 2032
                           8.1.2.6 Spain
                               8.1.2.6.1 Spain market estimates and forecast, 2020 - 2032
                       8.1.3 Asia Pacific
                           8.1.3.1 Asia Pacific market estimates and forecast, 2020 - 2032
                           8.1.3.2 Japan
                               8.1.3.2.1 Japan market estimates and forecast, 2020 - 2032
                           8.1.3.3 India
                               8.1.3.3.1 India market estimates and forecast, 2020 - 2032
                           8.1.3.4 Australia
                               8.1.3.4.1 Australia market estimates and forecast, 2020 - 2032
                           8.1.3.5 China
                               8.1.3.5.1 China market estimates and forecast, 2020 - 2032
                       8.1.4 Latin America
                           8.1.4.1 Latin America market estimates and forecast, 2020 - 2032
                           8.1.4.2 Brazil
                               8.1.4.2.1 Brazil market estimates and forecast, 2020 - 2032
                           8.1.4.3 Mexico
                               8.1.4.3.1 Mexico market estimates and forecast, 2020 - 2032
                           8.1.4.4 Argentina
                               8.1.4.4.1 Argentina market estimates and forecast, 2020 - 2032
                       8.1.5 Middle East And Africa
                           8.1.5.1 Middle East & Africa market estimates and forecast, 2020 - 2032
                           8.1.5.2 South Africa
                               8.1.5.2.1 South Africa market estimates and forecast, 2020 - 2032
                           8.1.5.3 Saudi Arabia
                               8.1.5.3.1 Saudi Arabia market estimates and forecast, 2020 - 2032
                           8.1.5.4 UAE
                               8.1.5.4.1 UAE market estimates and forecast, 2020 - 2032
Chapter 9 Real-time PCR (qPCR), end-point PCR, and dPCR Market - Competitive Landscape
                   9.1 Company Profiles
                       9.1.1 ABBOTT
                           9.1.1.1 Company overview
                           9.1.1.2 Financial performance
                           9.1.1.3 Product benchmarking
                           9.1.1.4 Strategic initiatives
                       9.1.2 QIAGEN
                           9.1.2.1 Company overview
                           9.1.2.2 Financial performance
                           9.1.2.3 Product benchmarking
                           9.1.2.4 Strategic initiatives
                       9.1.3 BIO-RAD LABORATORIES, INC.
                           9.1.3.1 Company overview
                           9.1.3.2 Financial performance
                           9.1.3.3 Product benchmarking
                           9.1.3.4 Strategic initiatives
                       9.1.4 AGILENT TECHNOLOGIES, INC.
                           9.1.4.1 Company overview
                           9.1.4.2 Financial performance
                           9.1.4.3 Product benchmarking
                           9.1.4.4 Strategic initiatives
                       9.1.5 THERMO FISHER SCIENTIFIC, INC.
                           9.1.5.1 Company overview
                           9.1.5.2 Affymetrix
                           9.1.5.3 Company overview
                           9.1.5.4 Financial performance
                           9.1.5.5 Product benchmarking
                           9.1.5.6 Strategic initiatives
                       9.1.6 CYTIVA (GE HEALTHCARE)
                           9.1.6.1 Company overview
                           9.1.6.2 Financial performance
                           9.1.6.3 Product benchmarking
                           9.1.6.4 Strategic initiatives
                       9.1.7 BIOMÉRIEUX SA
                           9.1.7.1 Company overview
                           9.1.7.2 Financial performance
                           9.1.7.3 Product benchmarking
                           9.1.7.4 Strategic initiatives
                       9.1.8 F. HOFFMANN-LA ROCHE LTD.
                           9.1.8.1 Company overview
                           9.1.8.2 Financial performance
                           9.1.8.3 Product benchmarking
                           9.1.8.4 Strategic initiatives
                       9.1.9 FLUIDIGM CORPORATION
                           9.1.9.1 Company overview
                           9.1.9.2 Financial performance
                           9.1.9.3 Product benchmarking
                           9.1.9.4 Strategic initiatives
                       9.1.10 STILLA
                           9.1.10.1 COMPANY OVERVIEW
                           9.1.10.2 Product benchmarking
                           9.1.10.3 Strategic initiatives
                       9.1.11 MICROSYNTH AG
                           9.1.11.1 Company overview
                           9.1.11.2 Product benchmarking
                           9.1.11.3 Strategic initiatives
                       9.1.12 JN MEDSYS
                           9.1.12.1 Company overview
                           9.1.12.2 Product benchmarking
                           9.1.12.3 Strategic initiatives
                       9.1.13 DANAHER
                           9.1.13.1 Company overview
                           9.1.13.2 Cepheid
                           9.1.13.3 Financial performance
                           9.1.13.4 Product benchmarking
                           9.1.13.5 Strategic initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert